EW

Key Statistics

Latest News

Edwards Lifesciences Insider Sold Shares Worth $2,012,076, According to a Recent SEC Filing

MT Newswires 17 hours ago

Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose

Business Wire 1 day ago

How The Edwards Lifesciences (EW) Investment Story Is Shifting After Mixed Analyst Revisions

Simply Wall St. 1 day ago

Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed

Zacks 3 days ago

NEW SURVEY BY EDWARDS LIFESCIENCES UNCOVERS JUST HOW MUCH AMERICANS KNOW ABOUT THEIR HEART HEALTH

PR Newswire 3 days ago

Community Sentiment

Sign in to vote

0 votes

Discussion (0)

About Edwards Lifesciences Corporatio

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.